Stockreport

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yah...

MAIA Biotechnology, Inc.  (MAIA) 
PDF Poster to highlight long-term therapeutic benefits of THIO sequenced with cemiplimab beyond treatment cessation CHICAGO, November 05, 2024 BUSINESS WIRE MAIA Biotechn [Read more]